Sparrow Pharmaceuticals

Developer of drugs for the treatment of endocrine disorders

placeChicago, Illinois, United States calendar_todayFounded 2013 groups10 employees language sparrowpharma.com

Social engagement

Social engagement: 3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Orbimed, RA Capital Management, Forbion.

Investor typeCountShare
Venture capital571%
Accelerator & incubator114%
Other / undisclosed114%

Recent activity

11 Jun 2026
Event
BIO2026 panel discussion on precision medicine approaches
3 Jun 2026
Event
ENDO2026
29 May 2026
Event
85th Scientific Sessions of the American Diabetes Association
Coming soon